Medical advice on whether Trelagliptin must be taken long-term once started
Trelagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor mainly used to treat type 2 diabetes (T2DM). By inhibiting DPP-4 enzyme activity, trolagliptin can prolong the action time of endogenous glucagon-like peptide-1 (GLP-1) in the body, promote insulin secretion and inhibit glucagon release, thereby achieving the effect of lowering blood sugar. Its characteristic is that it only needs to be taken orally once a day, and it has relatively stable blood sugar control and relatively mild side effects.
Comprehensive medicine recommends that once you start taking trelagliptin, you should continue to take it under the guidance of a doctor and avoid stopping the drug on your own to prevent blood sugar rebound and the risk of diabetic complications. Regular monitoring of blood sugar, glycosylated hemoglobin (HbA1c) and liver and kidney function indicators, combined with healthy diet and regular exercise, can effectively improve long-term efficacy and safety. Doctors will evaluate whether the dose can be adjusted or combined with other drugs based on the patient's individual situation to achieve a balance between blood sugar stability and quality of life.
Reference link: https://www.drugs.com
From a medical perspective, trolagliptin cannot cure type 2 diabetes. Its main function is to improve pancreatic beta cell function and regulate blood sugar levels. Once started, if the patient stops taking the drug, DPP-4 activity in the body will resume, GLP-1 levels will drop, and blood sugar may rise again. Therefore, for most patients, long-term or even lifelong maintenance treatment with troagliptin is required to continue to control blood sugar and reduce the risk of complications.
Comprehensive medicine recommends that once you start taking trelagliptin, you should continue to take it under the guidance of a doctor and avoid stopping the drug on your own to prevent blood sugar rebound and the risk of diabetic complications. Regular monitoring of blood sugar, glycosylated hemoglobin (HbA1c) and liver and kidney function indicators, combined with healthy diet and regular exercise, can effectively improve long-term efficacy and safety. Doctors will evaluate whether the dose can be adjusted or combined with other drugs based on the patient's individual situation to achieve a balance between blood sugar stability and quality of life.
Reference link: https://www.drugs.com
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)